Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Celgene earnings rise in quarter
Marketwatch
Thursday, October 22, 2009 - 9:13am
tags:
Celgene, earnings
Pick Up Antigenics at a Bargain Price
Seeking Alpha
Thursday, October 22, 2009 - 9:11am
tags:
Antigenics, Oncophage
Teva seeking to sell generic version of Cephalon’s Nuvigil sleep disorder drug
Bizjournals.com
Thursday, October 22, 2009 - 9:10am
tags:
Cephalon, NUVIGIL, Teva Pharmaceuticals, generics
Novartis Faces A Trial In Sex Discrimination Lawsuit Filed By Female Sales Reps
Pharmalot
Thursday, October 22, 2009 - 9:07am
tags:
discrimination, Novartis, lawsuits
Pfizer Won't Share Wyeth's Q3 Numbers; Layoff Announcements Due This Week
BNET Pharma
Thursday, October 22, 2009 - 9:05am
tags:
Pfizer, Wyeth, M&A, layoffs, reorganization
Bristol-Myers’ Profit Rises, Tops Analyst Estimates
Bloomberg
Thursday, October 22, 2009 - 9:04am
tags:
Bristol-Myers Squibb, earnings
GE, Lilly Develop Test to Improve Cancer Treatments
Bloomberg
Thursday, October 22, 2009 - 9:03am
tags:
cancer, Eli Lilly, GE, drug development
Merck's quarterly net profit triples on asset sale
Marketwatch
Thursday, October 22, 2009 - 8:58am
tags:
Merck, earnings
Schering-Plough net income falls 17%
Marketwatch
Thursday, October 22, 2009 - 7:03am
tags:
Schering Plough, earnings
Novartis Ups Sales Forecast as Profits Rise
TheStreet.com
Thursday, October 22, 2009 - 6:56am
tags:
Novartis, earnings
What will happen when Viagra goes generic?
AccessRx
Wednesday, October 21, 2009 - 6:00pm
tags:
generics, Viagra, patents, Pfizer
Earnings Preview: Bristol-Myers Squibb
Seeking Alpha
Wednesday, October 21, 2009 - 5:18pm
tags:
Bristol-Myers Squibb, earnings
FDA requests additional studies for Amgen drug
Marketwatch
Wednesday, October 21, 2009 - 5:16pm
tags:
Amgen, Prolia, FDA, denosumab
Merck 3Q earnings report comes as it works to close its $41 billion buyout of Schering-Plough
Yahoo/AP
Wednesday, October 21, 2009 - 5:15pm
tags:
Merck, earnings, M&A, Schering Plough
Amgen reports higher third-quarter profit
Marketwatch
Wednesday, October 21, 2009 - 5:13pm
tags:
Amgen, earnings
Earnings Preview: Celgene
Seeking Alpha
Wednesday, October 21, 2009 - 2:35pm
tags:
earnings, Celgene
Earnings Preview: Amgen
Seeking Alpha
Wednesday, October 21, 2009 - 2:35pm
tags:
earnings, Amgen
NICE stiff-arms Glaxo's Tyverb--again
Fierce Pharma
Wednesday, October 21, 2009 - 2:34pm
tags:
UK, GSK, Tyverb, breast cancer
King Pharmaceuticals gets FDA request on stress imaging agent, potentially delaying approval
Yahoo/AP
Wednesday, October 21, 2009 - 2:32pm
tags:
King, imaging, FDA, Corvue
Pharma at the tipping point II: Emerging markets
Eye for Pharma
Wednesday, October 21, 2009 - 10:59am
tags:
pharma industry

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.